Hypocitrauria as a Major Metabolic Abnormality in Pediatric Urolithiasis and Nephrocalcinosis

Authors

  • Sasipa Muensri Department of Bilochemistry, Faculty of Medicine, Chulalongkorn University
  • Piyaratana Tosukhowong Department of Bilochemistry, Faculty of Medicine, Chulalongkorn University
  • Ankanee Chanakul Department of Prediatrics, Faculty of Medicine, Chulalongkorn University
  • Wattanachai Ungjaroenwathana Section of Urology, Department of Surgery, Suppasit Prasong Hospital
  • Vorasak Shotelersuk Department of Prediatrics, Faculty of Medicine, Chulalongkorn University
  • Chanchai Boonla Department of Bilochemistry, Faculty of Medicine, Chulalongkorn University

Keywords:

urolithiasis, nephrocalcinosis, metabolic abnormality, hypocitrauria, hypercalciuria, hyperoxaluria

Abstract

Objective: To determine calcium, oxalate, uric acid, potassium, magnesium and citrate in urines of childhood urolithaisis (UL) patients and childhood nephrocalcinosis (NC) compared to non-stone forming (NSF) children.

Method: Seven pediatric UL and 7 pediatric NC patients were recruited for the study. Urine (24-hour urine or spot urine) and stone specimens were collected. Twenty-seven NSF children served as controls were participated, and their spot urine samples were collected. Urinary levels of calcium, oxalate, uric acid, potassium, magnesium and citrate were determined.

Results: Urinary levels of citrate, potassium and magnesium in UL and NC patients were significantly lower than that in NSF controls. Urinary calcium in NC patients was significantly greater than the controls. Both UL and NC patients had urinary uric acid higher, while urinary oxalate lower, than the controls. Hypocitrauria (100%) were remarkably observed in childhood UL patients. Four children with NC (57.14%) had hypocitrauria whereas only 4% (1/27) was found in NSF children. The prevalence of hypercalciuria and hyperoxaluria in childhood UL patients and NSF children was not statistically different. Prevalence of hypercalciuria and hyperoxaluria in pediatric NC patients did not differ from the controls.

Conclusion: Hypocitrauria was considered as the main metabolic risk factors of UL and NC in Thai children. Modification in dietary habit as well as citrate supplementation is recommended to prevent recurrent urinary stone in UL patient and to decrease the likelihood of stone formation in NC patients.

Downloads

Download data is not yet available.

References

Erbagci A, Erbagci AB, Yilmaz M, Yagci F, Tarakcioglu M, Yurtseven C, et al. Pediatric urolithiasis--evaluation of risk factors in 95 children. Scand J Urol Nephrol 2003; 37(2): 129-33.

Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Hussain M, Zafar MN, et al. The management of stone disease. BJU Int 2002; 89 Suppl 1: 62-8.

Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor. J Urol 2000; 164(1):162-5.

Ece A, Ozdemir E, Gurkan F, Dokucu AI, Akdeniz O. Characteristics of pediatric urolithiasis in south-east Anatolia. Int J Urol 2000; 7(9): 330-4.6. Oner A, Demircin G, Ipekcioglu H, Bulbul M, Ecin N. Etiological and clinical patterns of urolithiasis in Turkish children. Eur Urol 1997; 31(4): 453-8.

Ali SH, Rifat UN. Etiological and clinical patterns of childhood urolithiasis in Iraq. Pediatr Nephrol 2005; 20(10): 1453-7.

Al-Rasheed SA, el-Faqih SR, Husain I, Abdurrahman M, al-Mugeirin MM. The aetiological and clinical pattern of childhood urolithiasis in Saudi Arabia. Int Urol Nephrol 1995; 27(4): 349-55.

Basaklar AC, Kale N. Experience with childhood urolithiasis. Report of 196 cases. Br J Urol 1991; 67(2): 203-5.

Sarkissian A, Babloyan A, Arikyants N, Hesse A, Blau N, Leumann E. Pediatric urolithiasis in Armenia: a study of 198 patients observed from 1991 to 1999. Pediatr Nephrol 2001; 16(9): 728-32.

Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol 1997; 4(6): 537-40.

Coward RJ, Peters CJ, Duffy PG, Corry D, Kellett MJ, Choong S, et al. Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child 2003; 88(11): 962-5.

Al-Eisa AA, Al-Hunayyan A, Gupta R. Pediatric urolithiasis in Kuwait. Int Urol Nephrol 2002; 33(1): 3-6.

Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc 1993; 68(3): 241-8.

Eveline A. Schell-Feith & Joana E. Kist-van Holthe & Albert J. van der Heijden. Nephrocalcinosis in preterm neonates. Pediatr Nephrol (2010) 25: 221-30.

Benjamin A. Vervaet, Anja Verhulst, Patrick C. DûHaese and Marc E. De Broe. Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant (2009) 24: 2030-5.

Sikora P, Roth B, Kribs A, Michalk DV, Hesse A, Hoppe B (2003).Hypocitraturia is one of the major risk factors for nephrocalcinosisin very low birth weight (VLBW) infants. Kidney Int 63: 2194-9.

Cameron MA, Sakhaee K, Moe OW. Nephrolithiasis in children. Pediatr Nephrol 2005; 20(11): 1587-92.

Stapleton FB. Childhood stones. Endocrinol Metab Clin North Am 2002; 31(4): 1001-15, ix.

Santos-Victoriano M, Brouhard BH, Cunningham RJ, 3rd. Renal stone disease in children. Clin Pediatr (Phila) 1998; 37(10): 583- 99.

Kamoun A, Daudon M, Abdelmoula J, Hamzaoui M, Chaouachi B, Houissa T, et al. Urolithiasis in Tunisian children: a study of 120 cases based on stone composition. Pediatr Nephrol 1999; 13(9): 920-5.

Youngjermchan P, et al. Hypocitraturia and hypokaliuria : major metabolic risk factors for kidney stone disease. Chula Med J Vol. 50 No. 9 September 2006

Kist-van Holthe JE, van Zwieten PH, Schell-Feith EA,Zonderland HM, Holscher HC, Wolterbeek R, Veen S, Frolich M, van der Heijden BJ (2007) Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function?. Pediatrics 119: 468-75.

Downloads

Published

2010-12-01

How to Cite

Muensri, S., Tosukhowong, P., Chanakul, A., Ungjaroenwathana, W., Shotelersuk, V., & Boonla, C. (2010). Hypocitrauria as a Major Metabolic Abnormality in Pediatric Urolithiasis and Nephrocalcinosis. Insight Urology, 31(2), 147–155. Retrieved from https://he02.tci-thaijo.org/index.php/TJU/article/view/252408

Issue

Section

Original article